Search for a doctor

Omar F. Abou Ezzeddine, M.D., M.S.

  1. Cardiologist
Request an Appointment

Publications

  1. Akhiyat N, Anand V, Kumar V, Ryu A, Gibbons R, Borlaug BA, Chandrasekaran K, Abou Ezzeddine O, Anavekar N. The myocardial function index (MFI): An integrated measure of cardiac function in AL-cardiomyopathy. Int J Cardiol Heart Vasc. 2024 Dec; 55:101525 Epub 2024 Oct 15
    View PubMed
  2. Sehrawat O, Swain WH, Alcantara HP, Tan NY, Abou Ezzeddine OF, Grogan M, Dispenzieri A, Lin G, Noseworthy PA, Siontis KC. Prognosis of patients with wild-type transthyretin cardiac amyloidosis and non-sustained ventricular tachycardia. J Cardiovasc Electrophysiol. 2024 Nov 6 Epub 2024 Nov 06
    View PubMed
  3. Cha YM, Lee HC, Mulpuru SK, Deshmukh AJ, Friedman PA, Asirvatham SJ, Bradley DJ, Madhavan M, Abou Ezzeddine OF, Wen S, Liddell BW, Curran C, Li C, Dasari S, Lanza IR, Bailey KR, Chen HH. Cardiac resynchronization therapy for patients with mild to moderately reduced ejection fraction and left bundle branch block. Heart Rhythm. 2024 Nov; 21 (11):2250-2259 Epub 2024 May 19
    View PubMed
  4. Sykora D, Rosenbaum AN, Churchill RA, Kim BM, Elwazir MY, Bois JP, Giudicessi JR, Bratcher M, Young KA, Ryan SM, Sugrue AM, Killu AM, Chareonthaitawee P, Kapa S, Deshmukh AJ, Abou Ezzeddine OF, Cooper LT, Siontis KC. Arrhythmic manifestations and outcomes of definite and probable cardiac sarcoidosis. Heart Rhythm. 2024 Oct; 21 (10):1978-1986 Epub 2024 Apr 06
    View PubMed
  5. Sykora D, Bratcher M, Churchill R, Kim BM, Elwazir M, Young K, Ryan S, Kolluri N, Abou Ezzeddine O, Bois J, Giudicessi J, Cooper L, Rosenbaum A. Medical Therapy and Clinical Outcomes in Cardiac Sarcoidosis Patients With Systolic Heart Failure. Circ J. 2024 Sep 3 Epub 2024 Sept 03
    View PubMed
  6. Kim BM, Sykora D, Rosenbaum AN, Ahmed E, Churchill RA, Bratcher M, Elwazir MY, Bois JP, Giudicessi JR, Sugrue AM, Killu AM, Kapa S, Deshmukh AJ, Asirvatham SJ, Cooper LT, Abou Ezzeddine OF, Siontis KC. Arrhythmic prognosis according to left ventricular systolic dysfunction severity in cardiac sarcoidosis. Heart Rhythm. 2024 Aug 28 [Epub ahead of print]
    View PubMed
  7. de Melo JF Jr, Mangold KE, Debertin J, Rosenbaum A, Bois JP, Attia ZI, Friedman PA, Deshmukh AJ, Kapa S, Cooper LT, Abou Ezzeddine OF, Siontis KC. Detection of cardiac sarcoidosis with the artificial intelligence-enhanced electrocardiogram. Heart Rhythm. 2024 Aug 8 Epub 2024 Aug 08
    View PubMed
  8. Ismayl M, Abbasi M, Al-Abcha A, El-Am E, Alkhouli M, Guerrero M, Dispenzieri A, Nkomo VT, Abou Ezzeddine OF, Grogan M, Anavekar NS. Outcomes of transcatheter aortic valve replacement in patients with and without amyloidosis: A nationwide analysis from the United States. Cardiovasc Revasc Med. 2024 Jan; 58:34-42 Epub 2023 July 17
    View PubMed
  9. Neves R, Tseng AS, Garmany R, Fink AL, McLeod CJ, Cooper LT, MacIntyre CJ, Homb AC, Rosenbaum AN, Bois JP, Abou Ezzeddine OF, Siontis KC, Pereira NL, Ackerman MJ, Giudicessi JR. Cardiac fludeoxyglucose-18 positron emission tomography in genotype-positive arrhythmogenic cardiomyopathy. Int J Cardiol. 2023 Oct 15; 389:131173 Epub 2023 July 08
    View PubMed
  10. Nandy S, Hajra A, Bandyopadhyay D, Malik A, Mankad R, Grogan M, Abou Ezzeddine O, Klarich KW. Trends in the Prevalence of Infiltrative Cardiomyopathy Among Patients With in-Hospital Cardiac Arrest. Curr Probl Cardiol. 2023 Oct; 48 (10):101819 Epub 2023 May 20
    View PubMed
  11. Castrichini M, Agboola KM, Vyas H, Abou Ezzeddine OF, Siontis KC, Giudicessi JR, Rosenbaum AN, Pereira NL. Cardiac Sarcoidosis Mimickers: Genetic Testing in Undifferentiated Inflammatory Cardiomyopathies. Circ Genom Precis Med. 2023 Oct; 16 (5):478-479 Epub 2023 July 04
    View PubMed
  12. Ingraham BS, AbouEzzeddine OF, Eleid MF, Reddy YNV. Dynamic Mitral Regurgitation-An Easy to Miss Reversible Cause of Severe Pulmonary Vascular Remodeling. Circ Heart Fail. 2023 Aug; 16 (8):e010735 Epub 2023 July 26
    View PubMed
  13. Young KA, Lyle M, Rosenbaum AN, Chang IC, Lin G, Bois MC, Ezzeddine OFA, Jouni H, Chareonthaitawee P, Kapa S, Grogan M, Cooper LT, Blauwet L, Bois JP. (18)F-FDG/(13)N-ammonia cardiac PET findings in ATTR cardiac amyloidosis. J Nucl Cardiol. 2023 Apr; 30 (2):726-735 Epub 2022 Jan 27
    View PubMed
  14. Sykora D, Young KA, Elwazir MY, Bois JP, Arment CA, Chareonthaitawee P, Kolluri N, Ezzeddine OFA, Cooper LT, Rosenbaum AN. The Mechanism and Natural History of Mitral Regurgitation in Cardiac Sarcoidosis. Am J Cardiol. 2023 Mar 15; 191:84-91 Epub 2023 Jan 18
    View PubMed
  15. Gonzalez-Lopez E, Escobar-Lopez L, Obici L, Saturi G, Bezard M, Saith SE, AbouEzzeddine OF, Mussinelli R, Gagliardi C, Kharoubi M, Griffin JM, Dispenzieri A, Vilches S, Perlini S, Longhi S, Oghina S, Rivas A, Grogan M, Maurer MS, Damy T, Palladini G, Rapezzi C, Garcia-Pavia P. Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms. JACC CardioOncol. 2022 Nov; 4 (4):442-454 Epub 2022 Nov 15
    View PubMed
  16. Sharain K, Homb A, Chareonthaitawee P, AbouEzzeddine OF. (99m)Technetium-pyrophosphate cardiac scintigraphy cases from a busy nuclear cardiology laboratory. J Nucl Cardiol. 2022 Oct; 29 (5):2157-2167 Epub 2021 July 19
    View PubMed
  17. Davies DR, Redfield MM, Scott CG, Minamisawa M, Grogan M, Dispenzieri A, Chareonthaitawee P, Shah AM, Shah SJ, Wehbe RM, Solomon SD, Reddy YNV, Borlaug BA, AbouEzzeddine OF. A Simple Score to Identify Increased Risk of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction. JAMA Cardiol. 2022 Oct 1; 7 (10):1036-1044
    View PubMed
  18. Shabtaie SA, Sehrawat O, Lee JZ, Cha YM, Mulpuru SK, Kowlgi NG, Siontis KC, Rosenbaum AN, Bois JP, AbouEzzeddine OF, Noseworthy PA, Asirvatham SJ, DeSimone CV, Deshmukh AJ. Cardiac resynchronization therapy response in cardiac sarcoidosis. J Cardiovasc Electrophysiol. 2022 Sep; 33 (9):2072-2080 Epub 2022 Aug 04
    View PubMed
  19. Elwazir MY, Bird JG, AbouEzzeddine OF, Chareonthaitawee P, Blauwet LA, Collins JD, Gibbons RJ, Rodriguez-Porcel M, Kamal HM, Abdellah AT, Bois JP. Performance of cardiac PET/CT with and without phase analysis for detection of scar in cardiac sarcoidosis: Comparison to cardiac magnetic resonance imaging. J Nucl Cardiol. 2022 Jun; 29 (3):1389-1401 Epub 2021 Jan 20
    View PubMed
  20. Ammirati E, AbouEzzeddine OF. Transthyretin amyloidosis in Western Europe: a snapshot from the THAOS registry and a call for further perspectives. Eur Heart J. 2022 Feb 3; 43 (5):401-404
    View PubMed
  21. Elwazir M, Krause ML, Bois JP, Christopoulos G, Kendi AT, Cooper JLT, Jouni H, AbouEzzeddine OF, Chareonthaitawee P, Abdelshafee M, Amin S. Rituximab for the Treatment of Refractory Cardiac Sarcoidosis: A Single-Center Experience. J Card Fail. 2022 Feb; 28(2):247-258. Epub 2021 Jul 25.
    View PubMed
  22. Kolluri N, Schmidt TJ, Elwazir MY, Kapa S, Abou Ezzeddine OF, Bois JP, Schirger JA, Rosenbaum AN, Cooper LT. Routine Laboratory Biomarkers As Prognostic Indicators of Cardiac Sarcoidosis Outcomes. Sarcoidosis Vasc Diffuse Lung Dis. 2022; 39 (3):e2022023 Epub 2022 Sept 23
    View PubMed
  23. Grogan M, Lopez-Jimenez F, Cohen-Shelly M, Dispenzieri A, Attia ZI, Abou Ezzedine OF, Lin G, Kapa S, Borgeson DD, Friedman PA, Murphree DH Jr. Artificial Intelligence-Enhanced Electrocardiogram for the Early Detection of Cardiac Amyloidosis. Mayo Clin Proc. 2021 Nov; 96 (11):2768-2778 Epub 2021 July 02
    View PubMed
  24. Harmon DM, AbouEzzeddine OF, McKie PM, Scott CG, Saenger AK, Jaffe AS. Sex-specific cut-off values for soluble suppression of tumorigenicity 2 (ST2) biomarker increase its cardiovascular prognostic value in the community. Biomarkers. 2021 Nov; 26 (7):639-646 Epub 2021 July 29
    View PubMed
  25. AbouEzzeddine OF, Davies DR, Scott CG, Fayyaz AU, Askew JW, McKie PM, Noseworthy PA, Johnson GB, Dunlay SM, Borlaug BA, Chareonthaitawee P, Roger VL, Dispenzieri A, Grogan M, Redfield MM. Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction. JAMA Cardiol. 2021 Nov 1; 6 (11):1267-1274
    View PubMed
  26. Ezzeddine FM, Kapa S, Rosenbaum A, Blauwet L, Deshmukh AJ, AbouEzzeddine OF, Maleszewski JJ, Asirvatham SJ, Bois JP, Schirger JA, Chareonthaitawee P, Siontis KC. Electrogram-guided endomyocardial biopsy yield in patients with suspected cardiac sarcoidosis and relation to outcomes. J Cardiovasc Electrophysiol. 2021 Sep; 32 (9):2486-2495 Epub 2021 Aug 09
    View PubMed
  27. Sharain K, AbouEzzeddine OF, Homb A, Chareonthaitawee P. Cardiac sarcoidosis cases from a busy nuclear cardiology laboratory. J Nucl Cardiol. 2021 Aug; 28 (4):1553-1568 Epub 2021 Feb 24
    View PubMed
  28. Rosenbaum AN, Kolluri N, Elwazir MY, Kapa S, Abou Ezzeddine OF, Bois JP, Chareonthaitawee P, Schmidt TJ, Cooper LT. Identification of a novel presumed cardiac sarcoidosis category for patients at high risk of disease. Int J Cardiol. 2021 Jul 15; 335:66-72 Epub 2021 Apr 18
    View PubMed
  29. Kolluri N, Elwazir MY, Rosenbaum AN, Maklady FA, AbouEzzeddine OF, Kapa S, Blauwet LA, Chareonthaitawee P, McBane RD 2nd, Bois JP. Effect of Corticosteroid Therapy in Patients With Cardiac Sarcoidosis on Frequency of Venous Thromboembolism. Am J Cardiol. 2021 Jun 15; 149:112-118 Epub 2021 Mar 20
    View PubMed
  30. Muchtar E, Dispenzieri A, Gertz MA, Kumar SK, Buadi FK, Leung N, Lacy MQ, Dingli D, Ailawadhi S, Bergsagel PL, Fonseca R, Hayman SR, Kapoor P, Grogan M, Abou Ezzeddine OF, Rosenthal JL, Mauermann M, Siddiqui M, Gonsalves WI, Kourelis TV, Larsen JT, Reeder CB, Warsame R, Go RS, Murray DL, McPhail ED, Dasari S, Jevremovic D, Kyle RA, Lin Y, Lust JA, Russell SJ, Hwa YL, Fonder AL, Hobbs MA, Rajkumar SV, Roy V, Sher T. Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update. Mayo Clin Proc. 2021 Jun; 96(6):1546-1577.
    View PubMed
  31. Thakkar S, Patel HP, Chowdhury M, Patel K, Kumar A, Arora S, Zahid S, Goel M, Barssoum K, Jain V, AbouEzzeddine OF, DeSimone CV, Baibhav B, Rao M, Deshmukh A. Impact of Arrhythmias on Hospitalizations in Patients With Cardiac Amyloidosis. Am J Cardiol. 2021 Mar 15; 143:125-130. Epub 2020 Dec 24.
    View PubMed
  32. El-Am EA, Grogan M, Ahmad A, Patlolla SH, Klarich KW, AbouEzzeddine OF, Melduni RM, Maleszewski JJ, Dispenzieri A, Nkomo VT. Persistence of Left Atrial Appendage Thrombus in Patients With Cardiac Amyloidosis. J Am Coll Cardiol 2021 Jan 26; 77 (3):342-343
    View PubMed
  33. Kourelis TV, Dasari SS, Dispenzieri A, Maleszewski JJ, Redfield MM, Fayyaz AU, Grogan M, Ramirez-Alvarado M, Abou Ezzeddine OF, McPhail ED. A Proteomic Atlas of Cardiac Amyloid Plaques. JACC CardioOncol. 2020 Nov; 2 (4):632-643 Epub 2020 Nov 17
    View PubMed
  34. Snipelisky D, Fudim M, Perez A, Nayor M, Lever NM, Raymer DS, Rosenbaum AN, AbouEzzeddine O, Hernandez AF, Stevenson LW, Gilstrap LG. Expected vs Actual Outcomes of Elective Initiation of Inotropic Therapy During Heart Failure Hospitalization. Mayo Clin Proc Innov Qual Outcomes. 2020 Oct; 4 (5):529-536 Epub 2020 Aug 19
    View PubMed
  35. Elwazir MY, Bois JP, Abou Ezzeddine OF, Chareonthaitawee P. Imaging and Quantification of Cardiac Sarcoidosis. Semin Nucl Med. 2020 Jul; 50 (4):283-294 Epub 2020 Apr 25
    View PubMed
  36. Reddy YNV, Rikhi A, Obokata M, Shah SJ, Lewis GD, AbouEzzedine OF, Dunlay S, McNulty S, Chakraborty H, Stevenson LW, Redfield MM, Borlaug BA. Quality of life in heart failure with preserved ejection fraction: importance of obesity, functional capacity, and physical inactivity. Eur J Heart Fail. 2020 Jun; 22 (6):1009-1018 Epub 2020 Mar 09
    View PubMed
  37. Elwazir MY, Bois JP, Abouezzeddine OF, Chareonthaitawee P. Imaging cardiac sarcoidosis and infiltrative diseases: diagnosis and therapeutic response. Q J Nucl Med Mol Imaging. 2020 Mar; 64 (1):51-73 Epub 2020 Jan 24
    View PubMed
  38. Fudim M, Kelly JP, Jones AD, AbouEzzeddine OF, Ambrosy AP, Greene SJ, Reddy YNV, Anstrom KJ, Alhanti B, Lewis GD, Hernandez AF, Felker GM. Are existing and emerging biomarkers associated with cardiorespiratory fitness in patients with chronic heart failure? Am Heart J. 2020 Feb; 220:97-107 Epub 2019 Nov 16
    View PubMed
  39. Reddy YNV, Obokata M, Testani JM, Felker GM, Tang WHW, Abou-Ezzeddine OF, Sun JL, Chakrabothy H, McNulty S, Shah SJ, Lewis GD, Stevenson LW, Redfield MM, Borlaug BA. Adverse Renal Response to Decongestion in the Obese Phenotype of Heart Failure With Preserved Ejection Fraction. J Card Fail. 2020 Feb; 26 (2):101-107 Epub 2019 Oct 13
    View PubMed
  40. Naddaf E, Paul P, AbouEzzeddine OF. Chloroquine and Hydroxychloroquine Myopathy: Clinical Spectrum and Treatment Outcomes. Front Neurol. 2020; 11:616075 Epub 2021 Feb 02
    View PubMed
  41. Muchtar E, Gertz MA, Lacy MQ, Go RS, Buadi FK, Dingli D, Grogan M, AbouEzzeddine OF, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa YL, Gonsalves W, Warsame R, Kourelis TV, Russell S, Lust JA, Lin Y, Zeldenrust S, Kyle RA, Rajkumar SV, Kumar SK, Dispenzieri A. Ten-year survivors in AL amyloidosis: characteristics and treatment pattern. Br J Haematol. 2019 Dec; 187 (5):588-594 Epub 2019 July 12
    View PubMed
  42. AbouEzzeddine OF, Kemp BJ, Borlaug BA, Mullan BP, Behfar A, Pislaru SV, Fudim M, Redfield MM, Chareonthaitawee P. Myocardial Energetics in Heart Failure With Preserved Ejection Fraction. Circ Heart Fail. 2019 Oct; 12 (10):e006240 Epub 2019 Oct 15
    View PubMed
  43. Reddy YNV, Lewis GD, Shah SJ, Obokata M, Abou-Ezzedine OF, Fudim M, Sun JL, Chakraborty H, McNulty S, LeWinter MM, Mann DL, Stevenson LW, Redfield MM, Borlaug BA. Characterization of the Obese Phenotype of Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study. Mayo Clin Proc. 2019 Jul; 94 (7):1199-1209
    View PubMed
  44. Chang IC, Scott CG, Dispenzieri A, AbouEzzeddine O, Lin G, Grogan M. Transthyretin amyloidosis in patients with undifferentiated heart failure. Amyloid. 2019; 26 (sup1):33-34
    View PubMed
  45. Fudim M, Ambrosy AP, Sun JL, Anstrom KJ, Bart BA, Butler J, AbouEzzeddine O, Greene SJ, Mentz RJ, Redfield MM, Reddy YNV, Vaduganathan M, Braunwald E, Hernandez AF, Borlaug BA, Felker GM. High-Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research Network. J Am Heart Assoc. 2018 Dec 18; 7 (24):e010364
    View PubMed
  46. Rosenbaum AN, AbouEzzeddine OF, Grogan M, Dispenzieri A, Kushwaha S, Clavell A, Daly RC, Edwards BS. Outcomes After Cardiac Transplant for Wild Type Transthyretin Amyloidosis. Transplantation. 2018 Nov; 102 (11):1909-1913
    View PubMed
  47. Grupper A, AbouEzzeddine OF, Maleszewski JJ, Grupper A, Geske JR, Kremers WK, Kushwaha SS, Pereira NL. Elevated ST2 levels are associated with antibody-mediated rejection in heart transplant recipients. Clin Transplant. 2018 Sep; 32 (9):e13349 Epub 2018 July 26
    View PubMed
  48. Groarke JD, Stevens SR, Mentz RJ, Cooper LB, Vader JM, AbouEzzeddine OF, Grodin JL, Joyce E, Anstrom KJ, Felker GM, Redfield MM, Stevenson LW, Lala A. Clinical Significance of Early Fluid and Weight Change During Acute Heart Failure Hospitalization. J Card Fail. 2018 Sep; 24 (9):542-549 Epub 2018 Jan 11
    View PubMed
  49. Napier R, McNulty SE, Eton DT, Redfield MM, AbouEzzeddine O, Dunlay SM. Comparing Measures to Assess Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction. JACC Heart Fail. 2018 Jul; 6 (7):552-560 Epub 2018 June 06
    View PubMed
  50. DuBrock HM, AbouEzzeddine OF, Redfield MM. High-sensitivity C-reactive protein in heart failure with preserved ejection fraction. PLoS One. 2018; 13 (8):e0201836 Epub 2018 Aug 16
    View PubMed
  51. Gilstrap LG, Snipelisky D, AbouEzzeddine O, Vader J, Cooper L, Kelley J, Perez A, Varian K, Lala A, Shah M, Stevenson LW. Unanswered Questions in Contemporary Heart Failure. J Card Fail. 2017 Oct; 23 (10):770-774 Epub 2017 July 06
    View PubMed
  52. Jenkins WS, Roger VL, Jaffe AS, Weston SA, AbouEzzeddine OF, Jiang R, Manemann SM, Enriquez-Sarano M. Prognostic Value of Soluble ST2 After Myocardial Infarction: A Community Perspective. Am J Med. 2017 Sep; 130(9):1112.e9-1112.e15. Epub 2017 Mar 23.
    View PubMed
  53. AbouEzzeddine OF, McKie PM, Dunlay SM, Stevens SR, Felker GM, Borlaug BA, Chen HH, Tracy RP, Braunwald E, Redfield MM. Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc. 2017 Feb 18; 6 (2)
    View PubMed
  54. Joyce E, Lala A, Stevens SR, Cooper LB, AbouEzzeddine OF, Groarke JD, Grodin JL, Braunwald E, Anstrom KJ, Redfield MM, Stevenson LW, Heart Failure Apprentice Network. Prevalence, Profile, and Prognosis of Severe Obesity in Contemporary Hospitalized Heart Failure Trial Populations. JACC Heart Fail. 2016 Dec; 4 (12):923-931
    View PubMed
  55. AbouEzzeddine OF, McKie PM, Scott CG, Rodeheffer RJ, Chen HH, Michael Felker G, Jaffe AS, Burnett JC, Redfield MM. Biomarker-based risk prediction in the community. Eur J Heart Fail. 2016 Nov; 18 (11):1342-1350
    View PubMed
  56. Grodin JL, Lala A, Stevens SR, DeVore AD, Cooper LB, AbouEzzeddine OF, Mentz RJ, Groarke JD, Joyce E, Rosenthal JL, Vader JM, Tang WH. Clinical Implications of Serum Albumin Levels in Acute Heart Failure: Insights From DOSE-AHF and ROSE-AHF. J Card Fail. 2016 Nov; 22 (11):884-890 Epub 2016 Feb 02
    View PubMed
  57. AbouEzzeddine OF, Wong YW, Mentz RJ, Raza SS, Nativi-Nicolau J, Kociol RD, McNulty SE, Anstrom KJ, Hernandez AF, Redfield MM, NHLBI Heart Failure Clinical Research Network. Evaluation of Novel Metrics of Symptom Relief in Acute Heart Failure: The Worst Symptom Score. J Card Fail. 2016 Nov; 22 (11):853-858 Epub 2015 Dec 21
    View PubMed
  58. Vader JM, LaRue SJ, Stevens SR, Mentz RJ, DeVore AD, Lala A, Groarke JD, AbouEzzeddine OF, Dunlay SM, Grodin JL, Davila-Roman VG, de las Fuentes L. Timing and Causes of Readmission After Acute Heart Failure Hospitalization-Insights From the Heart Failure Network Trials. J Card Fail. 2016 Nov; 22 (11):875-883 Epub 2016 Apr 28
    View PubMed
  59. Cooper LB, Mentz RJ, Gallup D, Lala A, DeVore AD, Vader JM, AbouEzzeddine OF, Bart BA, Anstrom KJ, Hernandez AF, Felker GM. Serum Bicarbonate in Acute Heart Failure: Relationship to Treatment Strategies and Clinical Outcomes. J Card Fail. 2016 Sep; 22 (9):738-42 Epub 2016 Jan 14
    View PubMed
  60. AbouEzzeddine OF, French B, Mirzoyev SA, Jaffe AS, Levy WC, Fang JC, Sweitzer NK, Cappola TP, Redfield MM. From statistical significance to clinical relevance: A simple algorithm to integrate brain natriuretic peptide and the Seattle Heart Failure Model for risk stratification in heart failure. J Heart Lung Transplant. 2016 Jun; 35 (6):714-21 Epub 2016 Jan 15
    View PubMed
  61. AbouEzzeddine OF, Lala A, Khazanie PP, Shah R, Ho JE, Chen HH, Pang PS, McNulty SE, Anstrom KJ, Hernandez AF, Redfield MM, NHLBI Heart Failure Clinical Research Network. Evaluation of a provocative dyspnea severity score in acute heart failure. Am Heart J. 2016 Feb; 172:34-41 Epub 2015 Oct 20
    View PubMed
  62. Lala A, McNulty SE, Mentz RJ, Dunlay SM, Vader JM, AbouEzzeddine OF, DeVore AD, Khazanie P, Redfield MM, Goldsmith SR, Bart BA, Anstrom KJ, Felker GM, Hernandez AF, Stevenson LW. Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF). Circ Heart Fail. 2015 Jul; 8 (4):741-8 Epub 2015 June 03
    View PubMed
  63. AbouEzzeddine OF, Haines P, Stevens S, Nativi-Nicolau J, Felker GM, Borlaug BA, Chen HH, Tracy RP, Braunwald E, Redfield MM. Galectin-3 in heart failure with preserved ejection fraction. A RELAX trial substudy (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure). JACC Heart Fail. 2015 Mar; 3 (3):245-52
    View PubMed
  64. Mentz RJ, Stevens SR, DeVore AD, Lala A, Vader JM, AbouEzzeddine OF, Khazanie P, Redfield MM, Stevenson LW, O'Connor CM, Goldsmith SR, Bart BA, Anstrom KJ, Hernandez AF, Braunwald E, Felker GM. Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure. JACC Heart Fail. 2015 Feb; 3 (2):97-107 Epub 2014 Oct 31
    View PubMed
  65. Mohammed SF, Hussain I, AbouEzzeddine OF, Takahama H, Kwon SH, Forfia P, Roger VL, Redfield MM. Right ventricular function in heart failure with preserved ejection fraction: a community-based study. Circulation. 2014 Dec 23; 130 (25):2310-20 Epub 2014 Nov 12
    View PubMed
  66. McKie PM, AbouEzzeddine OF, Scott CG, Mehta R, Rodeheffer RJ, Redfield MM, Burnett JC Jr, Jaffe AS. High-sensitivity troponin I and amino-terminal pro--B-type natriuretic peptide predict heart failure and mortality in the general population. Clin Chem. 2014 Sep; 60 (9):1225-33 Epub 2014 July 01
    View PubMed
  67. Chen HH, Anstrom KJ, Givertz MM, Stevenson LW, Semigran MJ, Goldsmith SR, Bart BA, Bull DA, Stehlik J, LeWinter MM, Konstam MA, Huggins GS, Rouleau JL, O'Meara E, Tang WH, Starling RC, Butler J, Deswal A, Felker GM, O'Connor CM, Bonita RE, Margulies KB, Cappola TP, Ofili EO, Mann DL, Davila-Roman VG, McNulty SE, Borlaug BA, Velazquez EJ, Lee KL, Shah MR, Hernandez AF, Braunwald E, Redfield MM, NHLBI Heart Failure Clinical Research Network. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA. 2013 Dec 18; 310 (23):2533-43
    View PubMed
  68. Chen HH, AbouEzzeddine OF, Anstrom KJ, Givertz MM, Bart BA, Felker GM, Hernandez AF, Lee KL, Braunwald E, Redfield MM, Heart Failure Clinical Research Network. Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial. Circ Heart Fail. 2013 Sep 1; 6 (5):1087-94
    View PubMed
  69. Habib A, Irfan M, Baddour LM, Le KY, Anavekar NS, Lohse CM, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, Sohail MR, Mayo Cardiovascular Infections Study Group . Impact of prior aspirin therapy on clinical manifestations of cardiovascular implantable electronic device infections. Europace. 2013 Feb; 15 (2):227-35 Epub 2012 Sept 05
    View PubMed
  70. Sohail MR, Hussain S, Le KY, Dib C, Lohse CM, Friedman PA, Hayes DL, Uslan DZ, Wilson WR, Steckelberg JM, Baddour LM, Mayo Cardiovascular Infections Study Group . Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections. J Interv Card Electrophysiol. 2011 Aug; 31 (2):171-83 Epub 2011 Mar 02
    View PubMed
  71. Abouezzeddine OF, Redfield MM. Who has advanced heart failure?: definition and epidemiology. Congest Heart Fail. 2011 Jul-Aug; 17 (4):160-8 Epub 2011 July 21
    View PubMed
  72. Swetz KM, Freeman MR, AbouEzzeddine OF, Carter KA, Boilson BA, Ottenberg AL, Park SJ, Mueller PS. Palliative medicine consultation for preparedness planning in patients receiving left ventricular assist devices as destination therapy. Mayo Clin Proc. 2011 Jun; 86 (6):493-500
    View PubMed
  73. LE KY, Sohail MR, Friedman PA, Uslan DZ, Cha SS, Hayes DL, Wilson WR, Steckelberg JM, Baddour LM, Mayo Cardiovascular Infections Study Group . Clinical predictors of cardiovascular implantable electronic device-related infective endocarditis. Pacing Clin Electrophysiol. 2011 Apr; 34 (4):450-9 Epub 2011 Jan 05
    View PubMed
  74. Boustani HN, Rohlmann A, Abouezzeddine O, Bergmann G, Zander T. Stiffening effect of a transsacral fusion system for the lumbosacral junction. A probabilistic finite elelment analysis and sensitivity study Orthopade. 2011; 40(2):162-168.
  75. Abouezzeddine O, Suleiman M, Buescher T, Kapa S, Friedman PA, Jahangir A, Mears JA, Ladewig DJ, Munger TM, Hammill SC, Packer DL, Asirvatham SJ. Relevance of endocavitary structures in ablation procedures for ventricular tachycardia. J Cardiovasc Electrophysiol. 2010 Mar; 21 (3):245-54 Epub 2009 Oct 08
    View PubMed
PST-20313640